0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lentivirus Particle Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-1S14830
Home | Market Reports | Science
Global Lentivirus Particle Market Research Report 2023
BUY CHAPTERS

Global Lentivirus Particle Market Research Report 2025

Code: QYRE-Auto-1S14830
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lentivirus Particle Market Size

The global market for Lentivirus Particle was valued at US$ 301 million in the year 2024 and is projected to reach a revised size of US$ 403 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Lentivirus Particle Market

Lentivirus Particle Market

Lentivirus particles have been widely used in biomedical research, particularly in the field of gene therapy and gene delivery. Lentiviruses, such as the human immunodeficiency virus (HIV), have been modified to be non-replicative and used as vectors to deliver genetic material into target cells. This delivery system enables the introduction of specific genes or genetic modifications into cells for various applications, including research, drug development, and potential therapeutic interventions.
The lentivirus particle market has seen significant growth due to the expanding interest in gene therapy, gene editing, and other genetic research applications. Lentiviral vectors offer several advantages, including their ability to infect both dividing and non-dividing cells, stable gene expression over extended periods, and a broad range of target cell compatibility.
Future development trends in the lentivirus particle market include:
Enhanced Safety and Efficiency: Ongoing research aims to improve the safety and efficiency of lentivirus-based gene delivery systems. This includes developing new vector designs, modifying viral components, and optimizing transduction protocols.
Targeted Delivery: Efforts are being made to enhance the specificity of lentiviral vectors by incorporating targeting ligands or using tissue-specific promoters. This enables more precise delivery of therapeutic genes to specific cell types or tissues.
Large-Scale Production: As demand for lentivirus particles increases, there is a need for scalable and cost-effective production methods. Advances in large-scale manufacturing techniques and purification processes are anticipated to support the growth of the market.
Regulatory Considerations: The lentivirus particle market is subject to regulatory oversight due to safety concerns associated with the use of viral vectors. Future developments may involve addressing regulatory requirements and guidelines to ensure safe and effective use of lentiviral-based therapies.
This report aims to provide a comprehensive presentation of the global market for Lentivirus Particle, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lentivirus Particle.
The Lentivirus Particle market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lentivirus Particle market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lentivirus Particle companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Lentivirus Particle Market Report

Report Metric Details
Report Name Lentivirus Particle Market
Accounted market size in year US$ 301 million
Forecasted market size in 2031 US$ 403 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Custom-made
  • Pre-made
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AMSBIO, Creative Biogene, Cellomics Technology, GenTarget, Takara Bio, GeneCopoeia, OriGene, GenScript, Addgene, System Biosciences, BPS Bioscience, Charles River, Santa Cruz Biotechnology, Sigma-Aldrich
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Lentivirus Particle company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Lentivirus Particle Market growing?

Ans: The Lentivirus Particle Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Lentivirus Particle Market size in 2031?

Ans: The Lentivirus Particle Market size in 2031 will be US$ 403 million.

Who are the main players in the Lentivirus Particle Market report?

Ans: The main players in the Lentivirus Particle Market are AMSBIO, Creative Biogene, Cellomics Technology, GenTarget, Takara Bio, GeneCopoeia, OriGene, GenScript, Addgene, System Biosciences, BPS Bioscience, Charles River, Santa Cruz Biotechnology, Sigma-Aldrich

What are the Application segmentation covered in the Lentivirus Particle Market report?

Ans: The Applications covered in the Lentivirus Particle Market report are Gene Expression, Gene Editing, Cell Line Development, Gene Therapy, Others

What are the Type segmentation covered in the Lentivirus Particle Market report?

Ans: The Types covered in the Lentivirus Particle Market report are Custom-made, Pre-made

Recommended Reports

Lentivirus and Vectors

Gene Therapy Markets

Viral Vectors & CDMO

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lentivirus Particle Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Custom-made
1.2.3 Pre-made
1.3 Market by Application
1.3.1 Global Lentivirus Particle Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Gene Expression
1.3.3 Gene Editing
1.3.4 Cell Line Development
1.3.5 Gene Therapy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lentivirus Particle Market Perspective (2020-2031)
2.2 Global Lentivirus Particle Growth Trends by Region
2.2.1 Global Lentivirus Particle Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lentivirus Particle Historic Market Size by Region (2020-2025)
2.2.3 Lentivirus Particle Forecasted Market Size by Region (2026-2031)
2.3 Lentivirus Particle Market Dynamics
2.3.1 Lentivirus Particle Industry Trends
2.3.2 Lentivirus Particle Market Drivers
2.3.3 Lentivirus Particle Market Challenges
2.3.4 Lentivirus Particle Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lentivirus Particle Players by Revenue
3.1.1 Global Top Lentivirus Particle Players by Revenue (2020-2025)
3.1.2 Global Lentivirus Particle Revenue Market Share by Players (2020-2025)
3.2 Global Lentivirus Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lentivirus Particle Revenue
3.4 Global Lentivirus Particle Market Concentration Ratio
3.4.1 Global Lentivirus Particle Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lentivirus Particle Revenue in 2024
3.5 Global Key Players of Lentivirus Particle Head office and Area Served
3.6 Global Key Players of Lentivirus Particle, Product and Application
3.7 Global Key Players of Lentivirus Particle, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lentivirus Particle Breakdown Data by Type
4.1 Global Lentivirus Particle Historic Market Size by Type (2020-2025)
4.2 Global Lentivirus Particle Forecasted Market Size by Type (2026-2031)
5 Lentivirus Particle Breakdown Data by Application
5.1 Global Lentivirus Particle Historic Market Size by Application (2020-2025)
5.2 Global Lentivirus Particle Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lentivirus Particle Market Size (2020-2031)
6.2 North America Lentivirus Particle Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lentivirus Particle Market Size by Country (2020-2025)
6.4 North America Lentivirus Particle Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lentivirus Particle Market Size (2020-2031)
7.2 Europe Lentivirus Particle Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lentivirus Particle Market Size by Country (2020-2025)
7.4 Europe Lentivirus Particle Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lentivirus Particle Market Size (2020-2031)
8.2 Asia-Pacific Lentivirus Particle Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lentivirus Particle Market Size by Region (2020-2025)
8.4 Asia-Pacific Lentivirus Particle Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lentivirus Particle Market Size (2020-2031)
9.2 Latin America Lentivirus Particle Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lentivirus Particle Market Size by Country (2020-2025)
9.4 Latin America Lentivirus Particle Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lentivirus Particle Market Size (2020-2031)
10.2 Middle East & Africa Lentivirus Particle Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lentivirus Particle Market Size by Country (2020-2025)
10.4 Middle East & Africa Lentivirus Particle Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AMSBIO
11.1.1 AMSBIO Company Details
11.1.2 AMSBIO Business Overview
11.1.3 AMSBIO Lentivirus Particle Introduction
11.1.4 AMSBIO Revenue in Lentivirus Particle Business (2020-2025)
11.1.5 AMSBIO Recent Development
11.2 Creative Biogene
11.2.1 Creative Biogene Company Details
11.2.2 Creative Biogene Business Overview
11.2.3 Creative Biogene Lentivirus Particle Introduction
11.2.4 Creative Biogene Revenue in Lentivirus Particle Business (2020-2025)
11.2.5 Creative Biogene Recent Development
11.3 Cellomics Technology
11.3.1 Cellomics Technology Company Details
11.3.2 Cellomics Technology Business Overview
11.3.3 Cellomics Technology Lentivirus Particle Introduction
11.3.4 Cellomics Technology Revenue in Lentivirus Particle Business (2020-2025)
11.3.5 Cellomics Technology Recent Development
11.4 GenTarget
11.4.1 GenTarget Company Details
11.4.2 GenTarget Business Overview
11.4.3 GenTarget Lentivirus Particle Introduction
11.4.4 GenTarget Revenue in Lentivirus Particle Business (2020-2025)
11.4.5 GenTarget Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Lentivirus Particle Introduction
11.5.4 Takara Bio Revenue in Lentivirus Particle Business (2020-2025)
11.5.5 Takara Bio Recent Development
11.6 GeneCopoeia
11.6.1 GeneCopoeia Company Details
11.6.2 GeneCopoeia Business Overview
11.6.3 GeneCopoeia Lentivirus Particle Introduction
11.6.4 GeneCopoeia Revenue in Lentivirus Particle Business (2020-2025)
11.6.5 GeneCopoeia Recent Development
11.7 OriGene
11.7.1 OriGene Company Details
11.7.2 OriGene Business Overview
11.7.3 OriGene Lentivirus Particle Introduction
11.7.4 OriGene Revenue in Lentivirus Particle Business (2020-2025)
11.7.5 OriGene Recent Development
11.8 GenScript
11.8.1 GenScript Company Details
11.8.2 GenScript Business Overview
11.8.3 GenScript Lentivirus Particle Introduction
11.8.4 GenScript Revenue in Lentivirus Particle Business (2020-2025)
11.8.5 GenScript Recent Development
11.9 Addgene
11.9.1 Addgene Company Details
11.9.2 Addgene Business Overview
11.9.3 Addgene Lentivirus Particle Introduction
11.9.4 Addgene Revenue in Lentivirus Particle Business (2020-2025)
11.9.5 Addgene Recent Development
11.10 System Biosciences
11.10.1 System Biosciences Company Details
11.10.2 System Biosciences Business Overview
11.10.3 System Biosciences Lentivirus Particle Introduction
11.10.4 System Biosciences Revenue in Lentivirus Particle Business (2020-2025)
11.10.5 System Biosciences Recent Development
11.11 BPS Bioscience
11.11.1 BPS Bioscience Company Details
11.11.2 BPS Bioscience Business Overview
11.11.3 BPS Bioscience Lentivirus Particle Introduction
11.11.4 BPS Bioscience Revenue in Lentivirus Particle Business (2020-2025)
11.11.5 BPS Bioscience Recent Development
11.12 Charles River
11.12.1 Charles River Company Details
11.12.2 Charles River Business Overview
11.12.3 Charles River Lentivirus Particle Introduction
11.12.4 Charles River Revenue in Lentivirus Particle Business (2020-2025)
11.12.5 Charles River Recent Development
11.13 Santa Cruz Biotechnology
11.13.1 Santa Cruz Biotechnology Company Details
11.13.2 Santa Cruz Biotechnology Business Overview
11.13.3 Santa Cruz Biotechnology Lentivirus Particle Introduction
11.13.4 Santa Cruz Biotechnology Revenue in Lentivirus Particle Business (2020-2025)
11.13.5 Santa Cruz Biotechnology Recent Development
11.14 Sigma-Aldrich
11.14.1 Sigma-Aldrich Company Details
11.14.2 Sigma-Aldrich Business Overview
11.14.3 Sigma-Aldrich Lentivirus Particle Introduction
11.14.4 Sigma-Aldrich Revenue in Lentivirus Particle Business (2020-2025)
11.14.5 Sigma-Aldrich Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Lentivirus Particle Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Custom-made
 Table 3. Key Players of Pre-made
 Table 4. Global Lentivirus Particle Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Lentivirus Particle Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Lentivirus Particle Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Lentivirus Particle Market Share by Region (2020-2025)
 Table 8. Global Lentivirus Particle Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Lentivirus Particle Market Share by Region (2026-2031)
 Table 10. Lentivirus Particle Market Trends
 Table 11. Lentivirus Particle Market Drivers
 Table 12. Lentivirus Particle Market Challenges
 Table 13. Lentivirus Particle Market Restraints
 Table 14. Global Lentivirus Particle Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Lentivirus Particle Market Share by Players (2020-2025)
 Table 16. Global Top Lentivirus Particle Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lentivirus Particle as of 2024)
 Table 17. Ranking of Global Top Lentivirus Particle Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Lentivirus Particle Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Lentivirus Particle, Headquarters and Area Served
 Table 20. Global Key Players of Lentivirus Particle, Product and Application
 Table 21. Global Key Players of Lentivirus Particle, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Lentivirus Particle Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Lentivirus Particle Revenue Market Share by Type (2020-2025)
 Table 25. Global Lentivirus Particle Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Lentivirus Particle Revenue Market Share by Type (2026-2031)
 Table 27. Global Lentivirus Particle Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Lentivirus Particle Revenue Market Share by Application (2020-2025)
 Table 29. Global Lentivirus Particle Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Lentivirus Particle Revenue Market Share by Application (2026-2031)
 Table 31. North America Lentivirus Particle Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Lentivirus Particle Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Lentivirus Particle Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Lentivirus Particle Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Lentivirus Particle Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Lentivirus Particle Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Lentivirus Particle Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Lentivirus Particle Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Lentivirus Particle Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lentivirus Particle Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Lentivirus Particle Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Lentivirus Particle Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Lentivirus Particle Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Lentivirus Particle Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Lentivirus Particle Market Size by Country (2026-2031) & (US$ Million)
 Table 46. AMSBIO Company Details
 Table 47. AMSBIO Business Overview
 Table 48. AMSBIO Lentivirus Particle Product
 Table 49. AMSBIO Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 50. AMSBIO Recent Development
 Table 51. Creative Biogene Company Details
 Table 52. Creative Biogene Business Overview
 Table 53. Creative Biogene Lentivirus Particle Product
 Table 54. Creative Biogene Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 55. Creative Biogene Recent Development
 Table 56. Cellomics Technology Company Details
 Table 57. Cellomics Technology Business Overview
 Table 58. Cellomics Technology Lentivirus Particle Product
 Table 59. Cellomics Technology Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 60. Cellomics Technology Recent Development
 Table 61. GenTarget Company Details
 Table 62. GenTarget Business Overview
 Table 63. GenTarget Lentivirus Particle Product
 Table 64. GenTarget Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 65. GenTarget Recent Development
 Table 66. Takara Bio Company Details
 Table 67. Takara Bio Business Overview
 Table 68. Takara Bio Lentivirus Particle Product
 Table 69. Takara Bio Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 70. Takara Bio Recent Development
 Table 71. GeneCopoeia Company Details
 Table 72. GeneCopoeia Business Overview
 Table 73. GeneCopoeia Lentivirus Particle Product
 Table 74. GeneCopoeia Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 75. GeneCopoeia Recent Development
 Table 76. OriGene Company Details
 Table 77. OriGene Business Overview
 Table 78. OriGene Lentivirus Particle Product
 Table 79. OriGene Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 80. OriGene Recent Development
 Table 81. GenScript Company Details
 Table 82. GenScript Business Overview
 Table 83. GenScript Lentivirus Particle Product
 Table 84. GenScript Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 85. GenScript Recent Development
 Table 86. Addgene Company Details
 Table 87. Addgene Business Overview
 Table 88. Addgene Lentivirus Particle Product
 Table 89. Addgene Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 90. Addgene Recent Development
 Table 91. System Biosciences Company Details
 Table 92. System Biosciences Business Overview
 Table 93. System Biosciences Lentivirus Particle Product
 Table 94. System Biosciences Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 95. System Biosciences Recent Development
 Table 96. BPS Bioscience Company Details
 Table 97. BPS Bioscience Business Overview
 Table 98. BPS Bioscience Lentivirus Particle Product
 Table 99. BPS Bioscience Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 100. BPS Bioscience Recent Development
 Table 101. Charles River Company Details
 Table 102. Charles River Business Overview
 Table 103. Charles River Lentivirus Particle Product
 Table 104. Charles River Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 105. Charles River Recent Development
 Table 106. Santa Cruz Biotechnology Company Details
 Table 107. Santa Cruz Biotechnology Business Overview
 Table 108. Santa Cruz Biotechnology Lentivirus Particle Product
 Table 109. Santa Cruz Biotechnology Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 110. Santa Cruz Biotechnology Recent Development
 Table 111. Sigma-Aldrich Company Details
 Table 112. Sigma-Aldrich Business Overview
 Table 113. Sigma-Aldrich Lentivirus Particle Product
 Table 114. Sigma-Aldrich Revenue in Lentivirus Particle Business (2020-2025) & (US$ Million)
 Table 115. Sigma-Aldrich Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Lentivirus Particle Picture
 Figure 2. Global Lentivirus Particle Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lentivirus Particle Market Share by Type: 2024 VS 2031
 Figure 4. Custom-made Features
 Figure 5. Pre-made Features
 Figure 6. Global Lentivirus Particle Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lentivirus Particle Market Share by Application: 2024 VS 2031
 Figure 8. Gene Expression Case Studies
 Figure 9. Gene Editing Case Studies
 Figure 10. Cell Line Development Case Studies
 Figure 11. Gene Therapy Case Studies
 Figure 12. Others Case Studies
 Figure 13. Lentivirus Particle Report Years Considered
 Figure 14. Global Lentivirus Particle Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Lentivirus Particle Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Lentivirus Particle Market Share by Region: 2024 VS 2031
 Figure 17. Global Lentivirus Particle Market Share by Players in 2024
 Figure 18. Global Top Lentivirus Particle Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lentivirus Particle as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Lentivirus Particle Revenue in 2024
 Figure 20. North America Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Lentivirus Particle Market Share by Country (2020-2031)
 Figure 22. United States Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Lentivirus Particle Market Share by Country (2020-2031)
 Figure 26. Germany Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Lentivirus Particle Market Share by Region (2020-2031)
 Figure 34. China Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Lentivirus Particle Market Share by Country (2020-2031)
 Figure 42. Mexico Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Lentivirus Particle Market Share by Country (2020-2031)
 Figure 46. Turkey Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Lentivirus Particle Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. AMSBIO Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 50. Creative Biogene Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 51. Cellomics Technology Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 52. GenTarget Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 53. Takara Bio Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 54. GeneCopoeia Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 55. OriGene Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 56. GenScript Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 57. Addgene Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 58. System Biosciences Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 59. BPS Bioscience Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 60. Charles River Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 61. Santa Cruz Biotechnology Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 62. Sigma-Aldrich Revenue Growth Rate in Lentivirus Particle Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Ecology Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29H6022
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Robotics Paint Booth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3R7922
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart